Keith Katkin
Insider Reports History
- Location
- Irvine, CA
- Signature
- /s/ Michael A. Metzger, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Keith Katkin:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | Director | Common Stock | 124,000 | $2,605,240 | $21.01 | 04 Feb 2026 | Direct |
| Emergent BioSolutions Inc. | Director | Common Stock | 86,431 | $544,515 | $6.30 | 23 May 2025 | Direct |
| RIGEL PHARMACEUTICALS INC | Director | Common Stock | 25,000 | $43,750 | $1.75 | 19 May 2021 | Direct |
| Eledon Pharmaceuticals, Inc. | Director | Common Stock | 8,575 | $12,948 | $1.51 | 10 Jan 2026 | Direct |
| Emergent BioSolutions Inc. | Director | Stock Option (Right to Buy) | 41,572 | 30 Apr 2025 | Direct | ||
| RIGEL PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 30,000 | 19 May 2021 | Direct | ||
| Eledon Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | 10 Jan 2026 | Direct |
Insider Reports Filed by Keith Katkin
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 04 Feb 2026 | 1 | $0 | 4 | Director | 06 Feb 2026, 16:13 |
| ELDN | Eledon Pharmaceuticals, Inc. | 10 Jan 2026 | 2 | $0 | 4 | Director | 16 Jan 2026, 17:00 |
| EBS | Emergent BioSolutions Inc. | 23 May 2025 | 1 | -$49,417 | 4 | Director | 28 May 2025, 16:08 |
| SNDX | Syndax Pharmaceuticals Inc | 19 May 2025 | 1 | +$91,120 | 4 | Director | 19 May 2025, 16:01 |
| EBS | Emergent BioSolutions Inc. | 30 Apr 2025 | 2 | $0 | 4 | Director | 02 May 2025, 20:30 |
| SNDX | Syndax Pharmaceuticals Inc | 05 Feb 2025 | 1 | $0 | 4 | Director | 07 Feb 2025, 16:37 |
| ELDN | Eledon Pharmaceuticals, Inc. | 10 Jan 2025 | 2 | $0 | 4 | Director | 13 Jan 2025, 17:30 |
| EBS | Emergent BioSolutions Inc. | 23 May 2024 | 2 | $0 | 4 | Director | 28 May 2024, 21:41 |
| SNDX | Syndax Pharmaceuticals Inc | 07 Feb 2024 | 1 | $0 | 4 | Director | 09 Feb 2024, 16:04 |
| EBS | Emergent BioSolutions Inc. | 25 May 2023 | 1 | $0 | 4 | Director | 30 May 2023, 19:05 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 May 2023 | 1 | $0 | 4 | Director | 02 May 2023, 18:45 |
| SNDX | Syndax Pharmaceuticals Inc | 02 Feb 2023 | 1 | $0 | 4 | Director | 03 Feb 2023, 15:52 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 Feb 2023 | 1 | $0 | 4 | Director | 02 Feb 2023, 17:04 |
| SNDX | Syndax Pharmaceuticals Inc | 06 Oct 2022 | 6 | -$529,234 | 4 | Director | 07 Oct 2022, 16:05 |
| SNDX | Syndax Pharmaceuticals Inc | 30 Sep 2022 | 18 | -$69,534 | 4 | Director | 04 Oct 2022, 17:49 |
| EBS | Emergent BioSolutions Inc. | 02 Apr 2022 | 1 | $0 | 4 | Director | 05 Apr 2022, 16:22 |
| EBS | Emergent BioSolutions Inc. | 01 Apr 2022 | 0 | $0 | 3 | Director | 05 Apr 2022, 16:18 |
| SNDX | Syndax Pharmaceuticals Inc | 02 Feb 2022 | 1 | $0 | 4 | Director | 03 Feb 2022, 16:30 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Director | 02 Feb 2022, 16:30 |
| RIGL | RIGEL PHARMACEUTICALS INC | 19 May 2021 | 2 | $0 | 4 | Director | 21 May 2021, 20:57 |